Fibich, Leebron, Copeland & Briggs is proud to announce that two of
our firm’s Partners -
Tommy Fibich and
Russ Briggs - were instrumental in the coordination of a
$2.4 billion dollar settlement for Actos bladder cancer lawsuits.
The settlement - which was reached on Tuesday April 28
th - is intended to compensate thousands of individuals who were allegedly
diagnosed with bladder cancer after taking Actos - a prescription diabetes
medication manufactured by Takeda Pharmaceuticals.
The case involved over 3,900 plaintiffs whose cases were consolidated in
Illinois Circuit Court of Cook County. Tommy Fibich served as co-lead
counsel and negotiating counsel.
Our firm congratulates Partners Fibich and Briggs on their significant
victory - which can help thousands of families who were affected by cancer
after taking Actos. You can read more about the settlement and their involvement on this
press release or this
New York Times article.